FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
178 listings in the last 30 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Ascorbic acid | Ascorbic acid 500 mg/mL | InjectionIntravenous | Zydus Pharmaceuticals USA Inc. | Sep 28, 2026 | 70710-2164 |
| Ascorbic acid | Ascorbic acid 500 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | Sep 28, 2026 | 70771-1943 |
| Ascorbic acid | Ascorbic acid 500 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | Sep 28, 2026 | 70771-1944 |
| Ascorbic acid | Ascorbic acid 500 mg/mL | InjectionIntravenous | Zydus Lifesciences Limited | Sep 28, 2026 | 70771-1945 |
| Lidocaine | Lidocaine 50 mg/g | OintmentTopical | Direct_Rx | Sep 28, 2026 | 72189-692 |
| Impavidomiltefosine | Miltefosine 50 mg/1 | CapsuleOral | Eton Pharmaceuticals, Inc. | Sep 26, 2026 | 71863-135 |
| Juvmotavapadon | Tavapadon .25 mg/1 | TabletOral | AbbVie Inc. | Sep 25, 2026 | 0074-5925 |
| Juvmotavapadon | — | Kit | AbbVie Inc. | Sep 25, 2026 | 0074-6090 |
| Juvmotavapadon | Tavapadon 5 mg/1 | TabletOral | AbbVie Inc. | Sep 25, 2026 | 0074-6105 |
| Juvmotavapadon | Tavapadon 10 mg/1 | TabletOral | AbbVie Inc. | Sep 25, 2026 | 0074-6210 |
| Juvmotavapadon | Tavapadon 15 mg/1 | TabletOral | AbbVie Inc. | Sep 25, 2026 | 0074-6315 |
| Metronidazole Vaginal Gelmetronidazole | Metronidazole 7.5 mg/g | GelVaginal | Aurobindo Pharma Limited | Sep 25, 2026 | 59651-703 |
| Foscarnet Sodium | Foscarnet sodium 24 mg/mL | Injection, SolutionIntravenous | Somerset Therapeutics, LLC | Sep 25, 2026 | 70069-864 |
| Deflazacort Oral Suspensiondeflazacort oral | Deflazacort 22.75 mg/mL | SuspensionOral | Biocon Pharma Inc. | Sep 25, 2026 | 70377-188 |
| Diphenhydraminediphenhydramine hydrochloride | Diphenhydramine hydrochloride 50 mg/mL | Injection, SolutionIntramuscular, Intravenous | REMEDYREPACK INC. | Sep 25, 2026 | 70518-4765 |
| Nortriptyline Hydrochloride | Nortriptyline hydrochloride 10 mg/1 | CapsuleOral | REMEDYREPACK INC. | Sep 25, 2026 | 70518-4766 |
| Thiamine Hydrochloride | Thiamine hydrochloride 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | Meitheal Pharmaceuticals Inc. | Sep 25, 2026 | 71288-804 |
| Yusimryadalimumab-aqvh | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | Meitheal Pharmaceuticals Inc. | Sep 25, 2026 | 71288-817 |
| Yusimryadalimumab-aqvh | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | Meitheal Pharmaceuticals Inc. | Sep 25, 2026 | 71288-818 |
| Physicians EZ Use M-predbupivacaine hydrochloride, methylprednisolone acetate, povidone-iodine | — | KitEpidural, Infiltration, Intramuscular, Intrasynovial, Soft tissue, Topical | Asclemed USA, Inc. | Sep 25, 2026 | 76420-216 |
| Atebriozzilurgisertib | Zilurgisertib fumarate 25 mg/1 | Tablet, Film coatedOral | Mirum Pharmaceuticals Inc. | Sep 25, 2026 | 79378-029 |
| Gobardenbendamustine hydrochloride | Bendamustine hydrochloride 100 mg/4mL | Injection, SolutionIntravenous | AVYXA Pharma, LLC | Sep 25, 2026 | 83831-176 |
| Ketrolac Tromethamineketorolac tromethamine | Ketorolac tromethamine 15 mg/mL | Injection, SolutionIntramuscular, Intravenous | Anthea Pharma Private Limited | Sep 25, 2026 | 83854-021 |
| Ketorolac Tromethamine | Ketorolac tromethamine 30 mg/mL | Injection, SolutionIntramuscular, Intravenous | Anthea Pharma Private Limited | Sep 25, 2026 | 83854-022 |
| Ketorolac Tromethamine | Ketorolac tromethamine 60 mg/2mL | Injection, SolutionIntramuscular | Anthea Pharma Private Limited | Sep 25, 2026 | 83854-024 |